Sign in
4

Changes in Ownership

ProMIS Neurosciences Inc. Filed Acc 0001927064-25-000002

Options or other derivatives

  • Chief Scientific Officer acquired 165,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cashman Neil Chief Scientific Officer 2025-09-22 Grant or award · Option (right to buy) +165,000 165,000 D
Loading xslF345X05/primary_doc.xml…